Dennis Phillip Andrew's Form 4 filing
NovaBridge Biosciences (NBP) · filed Sep 21, 2026
- Accession no.
- 0002089237-26-000008
- Filed
- Sep 21, 2026, 4:05 PM ET
- Trade date
- Sep 17-18, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.83K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dennis Phillip AndrewCIK 0002089237 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Ordinary Shares | MOption exerciseAcquired | +23,695 | – | – | 181,636 | Direct | |
| Sep 18, 2026 | Ordinary Shares | SSaleDisposed | −8,209 | $0.71 | −$5,828.39 | 173,427 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Ordinary Shares | MOption exerciseDisposed | −10,302 | $0.00 | $0 | 72,120 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.